Avalyn Pharma
PublicAvalyn Pharma is now publicly traded
The data on this page reflects Avalyn Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 1, 2026
Last Round
Series D
Jul 22, 2025
Total Funding Raised
$574.3M
Company Overview
Avalyn Pharma is a biopharmaceutical company that develops inhaled therapies for the treatment of rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
pulmonary fibrosisinhaled therapyinhalation deliverybiotechdrug-device combinationrespiratory diseaseinhaled pirfenidoneinhaled nintedanibclinical-stage biotechpulmonary drug deliveryILDinterstitial lung diseasedrug developmentpulmonology
Avalyn Pharma Comparables
Compare Avalyn Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Calluna Pharma | 56% | |
| InCarda Therapeutics | 56% | |
| Aquilon Pharmaceuticals | 50% | |
Avalyn Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 1, 2026 | ||||
| Series D | Jul 22, 2025 | ||||
| Series C | Sep 27, 2023 | ||||
| Series B | Apr 27, 2020 | ||||
| Series A | May 15, 2017 | ||||
Seed | Nov 8, 2012 |
Key People
Founding team and executive leadership
Avalyn Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series D |
| Perceptive Advisors | Series C, Series D |
| Heartland Healthcare Capital | Series C |
| Eventide Funds | Series D, Series C |
| Xontogeny | Series C |
| F-Prime Capital | Series C, Series B, Series A |
| Edmond de Rothschild | Series A |
Avalyn Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersCambridge, Massachusetts
Employee Range61
Year Founded2011
Last FundingJul 22, 2025